Valuation : Alcon

Market Cap 34.04B 29.28B 27.53B 25.13B 47.01B 3,219B 47.16B 326B 126B 1,649B 128B 125B 5,251B P/E 2026 *
39.6x
P/E 2027 * 25.1x
Enterprise Value 36.59B 31.46B 29.59B 27.01B 50.52B 3,460B 50.69B 351B 136B 1,772B 137B 134B 5,644B EV / Sales 2026 *
3.3x
EV / Sales 2027 * 3.01x
Free-Float
97.34%
Yield 2026 *
0.53%
Yield 2027 * 0.59%
Manager TitleAgeSince
Chief Executive Officer 60 2018-06-30
Director of Finance/CFO 58 2019-04-07
Chief Tech/Sci/R&D Officer - 2024-12-31
Director TitleAgeSince
Director/Board Member 60 -
Chairman 70 2018-06-30
Director/Board Member 63 2019-01-31
Change 5-day change 1-year change 3-year change Capi.($)
+0.32%-.--% - - 34.21B
-0.83%-7.36%-42.78%-14.31% 80.01B
-0.59%-2.73%-11.11%-22.84% 34.21B
-1.49%-0.71%+2.20%-21.31% 13.57B
+0.45%+3.86% - - 12.61B
+1.73%+2.44%-2.06%+581.44% 2.6B
-0.54%-0.99%-38.83%-57.70% 1.47B
-0.17%+10.88% - - 968M
-1.43%-5.01%+17.49%+2.43% 935M
-1.00%-0.97%-35.94%-19.99% 896M
Average -0.33%-1.07%-15.86%+63.96% 16.36B
Weighted average by Cap. -0.49%-3.92%-28.81%-6.02%

Financials

2026 *2027 *
Net sales 11.09B 9.54B 8.97B 8.19B 15.31B 1,049B 15.36B 106B 41.11B 537B 41.64B 40.73B 1,711B 11.77B 10.13B 9.52B 8.69B 16.26B 1,113B 16.31B 113B 43.65B 570B 44.21B 43.25B 1,816B
Net income 764M 657M 618M 564M 1.06B 72.27B 1.06B 7.33B 2.83B 37.01B 2.87B 2.81B 118B 1.26B 1.08B 1.02B 930M 1.74B 119B 1.74B 12.07B 4.67B 60.97B 4.73B 4.62B 194B
Net Debt 2.54B 2.19B 2.06B 1.88B 3.51B 241B 3.53B 24.41B 9.43B 123B 9.56B 9.35B 393B 1.45B 1.25B 1.17B 1.07B 2B 137B 2.01B 13.91B 5.38B 70.22B 5.45B 5.33B 224B
Logo Alcon
Alcon Inc. is the global leader in the design, manufacture and marketing of ophthalmic care products. Net sales break down by category of products as follows: - ophthalmic surgical products and equipment (55.7%): consumables (52.7% of net sales), implantable products (31%) and other products (16.3%; in particular surgical equipment) for the treatment of cataracts, retinal diseases, glaucoma and refractive errors; - vision care products (44.3%): contact lenses (60.6% of sales) and eye care products (39.4%; eye drops and ophthalmic ointments, etc.). At the end of 2025, the group operated 17 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (0.7%), the United States (45.1%), Japan (5.9%), China (5.5%), and Other (42.8%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
AAA
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!